The factors associated with a functional outcome after ischemic stroke in diabetic patients: The Fukuoka Stroke Registry

Journal of the Neurological Sciences

Volumn 313, Issue 1-2, 2012, Pages 110-114

  Kuwashiro, Takahiro ^a   Kamouchi, Masahiro ^a   Ago, Tetsuro ^a   Hata, Jun ^a   Sugimori, Hiroshi ^a   Kitazono, Takanari ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin receptor blocker; Diabetes mellitus; Ischemic stroke; Outcome; Proteinuria

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; SULFONYLUREA;

AGED; ARTICLE; BRAIN ISCHEMIA; DEMENTIA; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE REGISTRY; FEMALE; FUNCTIONAL STATUS; GROUPS BY AGE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEINURIA; REGISTRIES; STROKE; TREATMENT OUTCOME;

EID: 84855602094     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.09.012     Document Type: Article

References (36)

1. P.A. Wolf, R.B. D'Agostino, A.J. Belanger, and W.B. Kannel Probability of stroke: a risk profile from the Framingham Study Stroke 22 1991 312 318
2. F.B. Hu, M.J. Stampfer, S.M. Haffner, C.G. Solomon, W.C. Willett, and J.E. Manson Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes Diabetes Care 25 2002 1129 1134 (Pubitemid 41071162)
3. T. Jeerakathil, J.A. Johnson, S.H. Simpson, and S.R. Majumdar Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: a population-based cohort-study Stroke 38 2007 1739 1743 (Pubitemid 46847242)
4. S.E. Megherbi, C. Milan, D. Minier, G. Couvreur, G.V. Osseby, and K. Tilling Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project Stroke 34 2003 688 694 (Pubitemid 36307394)
5. T. Olsson, M. Viitanen, K. Asplund, S. Eriksson, and E. Hägg Prognosis after stroke in diabetic patients. A controlled prospective study Diabetologia 33 1990 244 249 (Pubitemid 20136242)
6. B. Fuentes, J. Castillo, B. San José, R. Leira, J. Serena, and J. Vivancos Stroke Project of the Cerebrovascular Diseases Study Group, Spanish Society of Neurology. The prognostic value of capillary glucose levels in acute stroke: the GLycemia in Acute Stroke (GLIAS) study Stroke 40 2009 562 568
7. T.A. Baird, M.W. Parsons, T. Phanh, K.S. Butcher, P.M. Desmond, and B.M. Tress Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome Stroke 34 2003 2208 2214 (Pubitemid 37099838)
8. S.E. Capes, D. Hunt, K. Malmberg, P. Pathak, and H.C. Gerstein Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview Stroke 32 2001 2426 2432 (Pubitemid 32954818)
9. T. Kuzuya, S. Nakagawa, J. Satoh, Y. Kanazawa, Y. Iwamoto, and M. Kobayashi Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus Diabetes Res Clin Pract 55 2002 65 85 (Pubitemid 34036538)
10. S. Matsuo, E. Imai, M. Horio, Y. Yasuda, K. Tomita, and K. Nitta Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 2009 982 992
11. H.P. Adams Jr., B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, and D.L. Gordon Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 1993 35 41 (Pubitemid 23014379)
12. G. Sulter, C. Steen, and J. De Keyser Use of the Barthel index and modified Rankin scale in acute stroke trials Stroke 30 1999 1538 1541 (Pubitemid 29379599)
13. C.T. Stier Jr., L.A. Adler, S. Levine, and P.N. Chander Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats J Hypertens Suppl 11 1993 S37 S42
14. Y. Nishimura, T. Ito, and J.M. Saavedra Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats Stroke 31 2000 2478 2486
15. W.J. Dai, A. Funk, T. Herdegen, T. Unger, and J. Culman Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats Stroke 30 1999 2391 2398
16. M. Iwai, H.W. Liu, R. Chen, A. Ide, S. Okamoto, and R. Hata Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation Circulation 110 2004 843 848 (Pubitemid 39096013)
17. K. Kario, J. Ishikawa, S. Hoshide, Y. Matsui, M. Morinari, and K. Eguchi Diabetic brain damage in hypertension: role of renin-angiotensin system Hypertension 45 2005 887 893 (Pubitemid 40628933)
18. L.H. Lindholm, H. Ibsen, B. Dahlöf, R.B. Devereux, G. Beevers, and U. de Faire Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 2002 1004 1010 (Pubitemid 34286537)
19. B.M. Brenner, M.E. Cooper, D. de Zeeuw, W.F. Keane, W.E. Mitch, and H.H. Parving Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 2001 861 869
20. E.J. Lewis, L.G. Hunsicker, W.R. Clarke, T. Berl, M.A. Pohl, and J.B. Lewis Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 2001 851 860
21. B. Fuentes, J. Fernández-Domínguez, M.A. Ortega-Casarrubios, B. SanJosé, P. Martínez-Sánchez, and E. Díez-Tejedor Treatment with angiotensin receptor blockers before stroke could exert a favourable effect in acute cerebral infarction J Hypertens 28 2010 575 581
22. Miyamoto N, Tanaka Y, Ueno Y, Tanaka R, Hattori N, Urabe T. Benefits of Prestrokev Use of Angiotensin Type 1 Receptor Blockers on Ischemic Stroke Severity. J Stroke Cerebrovasc Dis in press.
23. W.B. Kannel, M.J. Stampfer, W.P. Castelli, and J. Verter The prognostic significance of proteinuria: the Framingham study Am Heart J 108 1984 1347 1352 (Pubitemid 15210767)
24. G. Berton, T. Citro, R. Palmieri, S. Petucco, R. De Toni, and P. Palatini Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality Circulation 96 1997 3338 3345 (Pubitemid 27513403)
25. A. Szczudlik, W. Turaj, A. Słowik, and J. Strojny Microalbuminuria and hyperthermia independently predict long-term mortality in acute ischemic stroke patients Acta Neurol Scand 107 2003 96 101 (Pubitemid 36286796)
26. C. Yokota, K. Minematsu, A. Ito, K. Toyoda, H. Nagasawa, and T. Yamaguchi Albuminuria, but not metabolic syndrome, is a significant predictor of stroke recurrence in ischemic stroke J Neurol Sci 277 2009 50 53
27. A. Słowik, W. Turaj, T. Iskra, J. Strojny, and A. Szczudlik Microalbuminuria in nondiabetic patients with acute ischemic stroke: prevalence, clinical correlates, and prognostic significance Cerebrovasc Dis 14 2002 15 21 (Pubitemid 34827759)
28. H.C. Gerstein, J.F. Mann, Q. Yi, B. Zinman, S.F. Dinneen, and B. Hoogwerf Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 2001 421 426 (Pubitemid 32681484)
29. S. Savage, R.O. Estacio, B. Jeffers, and R.W. Schrier Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM Diabetes Care 19 1996 1243 1248 (Pubitemid 26363440)
30. T. Deckert, B. Feldt-Rasmussen, K. Borch-Johnsen, T. Jensen, and A. Kofoed-Enevoldsen Albuminuria reflects widespread vascular damage. The Steno hypothesis Diabetologia 32 1989 219 226 (Pubitemid 19136363)
31. P. Knöbl, G. Schernthaner, C. Schnack, P. Pietschmann, A. Griesmacher, and R. Prager Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients Diabetologia 36 1993 1045 1050 (Pubitemid 23288774)
32. F. Guerrero-Romero, and M. Rodríguez-Morán Proteinuria is an independent risk factor for ischemic stroke in non-insulin-dependent diabetes mellitus Stroke 30 1999 1787 1791 (Pubitemid 29411815)
33. H.P. Adams Jr., P.H. Davis, E.C. Leira, K.C. Chang, B.H. Bendixen, and W.R. Clarke Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Neurology 53 1999 126 131 (Pubitemid 29329660)
34. C. Weimar, I.R. König, K. Kraywinkel, A. Ziegler, H.C. Diener, and German Stroke Study Collaboration Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models Stroke 35 2004 158 162 (Pubitemid 38057612)
35. G. Saposnik, R. Cote, S. Phillips, G. Gubitz, N. Bayer, and J. Minuk for the Stroke Outcome Research Canada (SORCan) Working Group. Stroke outcome in those over 80. A Multicenter Cohort Study Across Canada Stroke 39 2008 2310 2317
36. N.E. Mayo, L. Nadeau, S.S. Daskalopoulou, and R. Côté The evolution of stroke in Quebec: a 15-year perspective Neurology 68 2007 1122 1127 (Pubitemid 46559846)